| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |